Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus

Journal of Medical Microbiology

Volumn 44, Issue 6, 1996, Pages 475-481

  Ricci, M Luisa ^a   Von Hunolstein, Christina ^a   Gomez, Maria J ^a   Parisi, Laura ^a   Tissi, Luciana ^b   Orefici, Graziella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; STREPTOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTHRITIS; DRUG EFFICACY; FEMALE; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 0030012570     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-44-6-475     Document Type: Article

References (29)

1. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant. Philadelphia, WB Saunders Company. 1983: 820-881.
2. Eykyn SJ, Young SEJ, Cookson BD. Increased community-acquired septicaemic infection with group B streptococci in adults. Lancet 1991; 338: 446.
3. Farley MM, Harvey RC, Stull T et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993; 328: 1807-1811.
4. Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci USA 1987; 84: 7208-7212.
5. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294: 753-756.
6. Fischer GW, Weisman LE, Hemming VG. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review. Clin Immunol Immunopathol 1992; 62: S92-S97.
7. Fischer GW, Weisman LB, Hemming VG et al. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans. Am J Med 1984; 76: S117-S123.
8. Kim KS, Wass CA, Kang JH, Anthony BF. Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus. J Infect Dis 1986; 153: 1092-1097.
9. Weisman LE, Anthony BF, Hemming VG, Fischer GW. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. J Pediatr 1993; 122: 929-937.
10. Egan ML, Pritchard DG, Dillon HC, Gray BM. Protection of mice from experimental infection with type III group B Streptococcus using monoclonal antibodies. J Exp Med 1983; 158: 1006-1011.
11. Shigeoka AO, Pincus SH, Rote NS, Hill HR. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus. J Infect Dis 1984; 149: 363-372.
12. Gray BM, Egan ML, Pritchard DG. Specificity of monoclonal antibodies against group B Streptococcus type II and inhibition of their binding by human secretions. Pediatr Res 1988; 24: 68-72.
13. Raff HV, Siscoe PJ, Wolff EA, Maloney G, Shuford W. Human monoclonal antibodies to group B Streptococcus. Reactivity and in vivo protection against multiple serotypes. J Exp Med 1988; 168: 905-917.
14. Teti G, Calapai M, Calogero G et al. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci. Hybridoma 1992; 11: 13-22.
15. Hill HR, Kelsey DK, Gonzales LA, Raff HV. Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease. Clin Immunol Immunopathol 1992; 62: S87-S91.
16. Tissi L, Marconi P, Mosci P et al. Experimental model of type IV Streptococcus agalactiae (Group B Streptococcus) infection in mice with early development of septic arthritis. Infect Immun 1990; 58: 3093-3100.
17. Rabinowitz S, Ferne M, Halfon ST. Group B streptococci: different serotypes associated with clinical infection. Lab Pract 1980; 29: 733-734.
18. Jelinková J, Motlová J. Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V. J Clin Microbiol 1985; 21: 361-362.
19. Wessels MR, Benedi VJ, Jennings HJ, Michon F, DiFabio JL, Kasper DL. Isolation and characterization of type IV group B Streptococcus capsular polysaccharide. Infect Immun 1989; 57: 1089-1094.
20. Molinari A, von Hunolstein C, Donelli G, Paradisi S, Arancia G, Orefici G. Effects of some capsular components on pathogenicity of type IV and provisional type V group B streptococci. FEMS Microbiol Lett 1987; 41: 69-72.
21. von Hunolstein C, D'ascenzi S, Wagner B et al. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (Group B streptococci). Infect Immun 1993; 61: 1272-1280.
22. Lancefield RC. A serological differentiation of specific types of bovine hemolytic streptococci (group B). J Exp Med 1934; 59: 441-458.
23. Malavasi F, Caligaris-Cappio F, Milanese C, Dellabona P, Richiardi P, Carbonara AO. Characterization of a murine monoclonal antibody specific for human early lymphohemapoietic cells. Human Immunol 1984; 9: 9-20.
24. Ouchterlony O. Diffusion-in-gel methods for immunological analysis. Prog Allergy 1958; 5: 1-78.
25. Reed L, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938; 27:493-397.
26. Lancefield RC, McCarty M, Everly WN. Multiple mouse-protective antibodies directed against group B streptococci. J Exp Med 1975; 142: 165-179.
27. Shigeoka AO, Hall RT, Hill HR. Blood-transfusion in group-B streptococcal sepsis. Lancet 1978; 1: 636-638.
28. Butkus Small C, Slater LN, Lowry FD, Small RD, Salvati EA, Casey JI. Group B streptococcal arthritis in adults. Am J Med 1984; 76: 367-375.
29. Raff HV, Bradley C, Brady W et al. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1. J Infect Dis 1991; 163: 346-354.